| Literature DB >> 29670922 |
Guangcan Chen1, Muming Xu2, Jingyao Chen3, Liangli Hong4, Wenting Lin3, Shukun Zhao3, Guohong Zhang3, Guo Dan3, Shuhui Liu3.
Abstract
The incidence of gastric cardia cancer (GCC) is high in China. However, the clinicopathological characteristics and the carcinogenesis of GCC are unclear. Toll-like receptor 4 (TLR4) is an important innate immunity receptor and has a role in non-GCC (NGCC). We compared the clinicopathological characteristics of GCC patients from a high-risk area in China to esophageal cancer (EC) patients. Immunohistochemistry for TLR4 was performed in 201 histological samples of normal gastric cardia mucosa (n = 11), gastric cardia inflammation (n = 87), and GCC (n = 103). We included 84 patients with EC and 99 with GCC. GCC tissue was more poorly differentiated than EC tissue and more invasive, with more histomorphologic variation. Lymph node metastasis was more frequent in GCC than in EC. The Helicobacter pylori infection rate was higher but not significantly with GCC than EC. Survival was shorter with lymph node metastasis. We found a statistically significant trend for progressive increase of TLR4 expression from normal mucosa to inflammation in GCC. GCC in this high-risk area displays clinicopathologic characteristics different from those of EC and different from those of gastroesophageal junction carcinomas in other countries, although this was not analyzed statistically. Increased TLR4 expression in gastric cardia lesions may be associated with GCC tumorigenesis.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29670922 PMCID: PMC5835293 DOI: 10.1155/2018/7132868
Source DB: PubMed Journal: J Immunol Res ISSN: 2314-7156 Impact factor: 4.818
Clinical and gross features of tumor patients with esophageal cancer (EC) and gastric cardia cancer (GCC).
| Features | EC | GCC |
|
|---|---|---|---|
| Male : female ratio | 63 : 21 | 84 : 15 | 0.095 |
| Age, years, mean ± SD | 57.14 ± 10.28 | 62.7 ± 7.79 | 0.003 |
| Size, cm, mean ± SD | 4.98 ± 1.51 | 5.92 ± 2.22 | 0.001 |
| Epicentre location, | |||
| Upper thoracic part | 9 (10.71) | — | |
| Middle thoracic part | 66 (78.57) | — | |
| Lower thoracic part | 9 (10.71) | — | |
| Gastric cardia | — | 99 |
Figure 1Representative images of gastric cardia cancer (GCC). (a) Gross image of GCC below the gastroesophageal junction (arrow). (b) Histology of GCC with tubular formation (arrow). (c) Histology of mucinous GCC, arrow indicating tumor cells. (d) Histology of small-cell undifferentiated carcinoma, arrow indicating tumor cells.
Figure 2Representative images of esophageal cancer (EC). (a) Gross image of EC (arrow). (b) Histology of squamous cell EC, arrow indicating cancer nest.
Comparison of histopathology and pathological staging.
| Microscopic features | EC | GCC |
|
|---|---|---|---|
|
| <0.001 | ||
| Well | 29 (34.5) | 5 (5.1) | |
| Moderate | 50 (59.5) | 49 (49.5) | |
| Poor | 5 (6.0) | 45 (45.5) | |
|
| |||
| Tubular adenocarcinoma | 0 (0) | 75 (75.8) | <0.001 |
| Mucinous carcinoma | 0 (0) | 16 (16.2) | |
| Small-cell undifferentiated carcinoma | 0 (0) | 2 (2.0) | |
| Squamous cell carcinoma | 84 (100) | 1 (1.0) | |
| Adenosquamous | 0 (0) | 4 (4.0) | |
| Neuroendocrine carcinoma | 0 (0) | 1 (1.0) | |
|
| 42 (50) | 72 (72.7) | 0.002 |
|
| 67 (70.8) | 92 (92.9) | 0.009 |
|
| |||
| 0 | 0 (0) | 0 (0) | <0.001 |
| 1 | 0 (0) | 5 (5.1) | |
| 2 | 40 (47.62) | 10 (10.1) | |
| 3 | 42 (50) | 84 (84.8) | |
| 4 | 2 (2.4) | 0 (0) |
Data are n (%).
Helicobacter pylori infection.
|
| EC | GCC |
|
|---|---|---|---|
| Positive | 19 (43.18) | 40 (48.19) | 0.59 |
| Negative | 25 (56.81) | 43 (51.81) |
Data are n (%).
Figure 3Kaplan-Meier survival curves for patients with GCC and EC. (a) Overall survival. (b) Cumulative survival with EC with and without lymph node metastasis. (c) Cumulative survival with GCC by TNM stage. 1: stage 1, 2: stage 2, 3: stage 3. (d) Cumulative survival with GCC with and without lymph node metastasis.
Immunohistochemical evaluation of TLR4 expression.
| Normal | Mild carditis | Severe carditis | Carcinoma | |
|---|---|---|---|---|
| TLR4 | 12.72 ± 15.71 | 28.63 ± 21.65∗ | 25.58 ± 22.23∗ | 63.67 ± 39.61∗# |
TLR4: Toll-like receptor 4. Data are mean ± SD; ∗P < 0.05 versus normal mucosa; #P < 0.05 versus mild or severe inflammation.
Figure 4Representative IHC staining for TLR4 in gastric cardia mucosae with different degrees of chronic inflammation: (a) normal, (b) mild inflammation, (c) severe inflammation, (d) no immunostaining in normal mucosae, (e) weak positive staining in mucosae with mild inflammation, and (f) moderate positive staining in mucosae with severe inflammation.
Figure 5IHC staining for TLR4 in GCC tissue. (a) Strong positive staining in well-differentiated GCC cases with tubular structure. (b) Negative TLR4 staining in poorly differentiated tumor.